Cargando…
Expected Net Benefit of Vaccinating Rangeland Sheep against Bluetongue Virus Using a Modified-Live versus Killed Virus Vaccine
Recurring outbreaks of bluetongue virus in domestic sheep of the US Intermountain West have prompted questions about the economic benefits and costs of vaccinating individual flocks against bluetongue (BT) disease. We estimate the cost of a BT outbreak on a representative rangeland sheep operation i...
Autores principales: | Munsick, Tristram R., Peck, Dannele E., Ritten, John P., Jones, Randall, Jones, Michelle, Miller, Myrna M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5641540/ https://www.ncbi.nlm.nih.gov/pubmed/29075635 http://dx.doi.org/10.3389/fvets.2017.00166 |
Ejemplares similares
-
Prospects of Next-Generation Vaccines for Bluetongue
por: van Rijn, Piet A.
Publicado: (2019) -
Vaccination With Recombinant Adenoviruses Expressing the Bluetongue Virus Subunits VP7 and VP2 Provides Protection Against Heterologous Virus Challenge
por: Rojas, José Manuel, et al.
Publicado: (2021) -
Identification and Characterization of Bluetongue Virus Serotype 14 in Russia
por: Koltsov, Andrei, et al.
Publicado: (2020) -
Ecological Dynamics Impacting Bluetongue Virus Transmission in North America
por: Mayo, Christie, et al.
Publicado: (2020) -
Reassortment of bluetongue virus vaccine serotypes in cattle
por: van den Bergh, Carien, et al.
Publicado: (2018)